Chief Medical Editor:
Terry Kim, MD
Professor of Ophthalmology
Duke University School of Medicine
Chief, Cornea and External Disease Division
Director, Refractive Surgery Service
Duke University Eye Center
Durham, NC
Faculty:
Elizabeth Yeu, MD
Assistant Professor of Ophthalmology
Eastern Virginia Medical School
Partner, Virginia Eye Consultants
Cornea, Cataract, Anterior Segment, and Refractive Surgery Specialist
Norfolk, VA
Reviewer:
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The author discloses that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Chief Medical Editor & faculty member report the following relationship(s):
Terry Kim, MD
Consulting Fee: Acucela, Aerie, Alcon/Novartis, Allergan/Actavis, Avedro, Avellino Labs, Bausch + Lomb/Valeant, BlephEx, CoDa/Ocunexus Therapeutics, Foresight, Kala, NovaBay, Ocular Therapeutix, Omeros, PowerVision, Presbyopia Therapies, Shire, SightLife Surgical, Simple Contacts, TearLab, TearScience
Ownership Interest: Kala, NovaBay, Ocular Therapeutix, Omeros, SightLife Surgical, Simple Contacts, TearScience
Elizabeth Yeu, MD
Speakers Bureau: Alcon, Allergan, ArcScan, Bausch + Lomb, Beaver Visitec, Bio-Tissue, iOptics, Johnson & Johnson Vision, LENSAR, Kala, Novartis, Ocular Science, Ocular Therapeutix, Ocusoft, Omeros, Science Based Health, Shire, SightLife, Sun Pharmaceutical, TearLab, TearScience, TopCon, Zeiss
Contracted Research: Alcon, Allergan, Bausch + Lomb, Bio-Tissue, iOptics, Ocular Science, Kala, TopCon
Ownership Interest: ArcScan, Modernizing Medicine, Ocular Science, SightLife, Strathspey Crown
Other Disclosure: Advisory Board: Alcon, Allergan, ArcScan, Bausch + Lomb, Bio-Tissue, iOptics, Johnson & Johnson Vision, Ocular Therapeutix, Ocusoft, SightLife, TearLab, TearScience
Reviewer reports the following relationship(s):
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.